Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Community pharmacy services

GP practices to directly refer patients to digital minor ailments scheme

Speaking at the Clinical Pharmacy Congress in London, NHS England’s Anne Joshua said GPs will trial different ways to refer patients to their community pharmacy.

Woman using smartphone


Patients accessing the NHS Urgent Medicine Supply Advanced Service on their mobile phones or devices will be given a code that they must show when they visit the pharmacy to collect their medicine

GP practices will refer patients to the pharmacy Digital Minor Illness Referral Service (DMIRS) directly from June 2019.

Anne Joshua, head of pharmacy strategy at NHS England, told the Clinical Pharmacy Congress that six sites across England would be piloting the service from June 2019, covering 54 pharmacies and 26 GP practices.

Speaking to The Pharmaceutical Journal, Joshua said the GP practices taking part in the pilot would be testing different systems to refer patients to a community pharmacy, including existing GP referral systems and online referral triage systems that some GP practices have adopted.

She said that although NHS England did not want to “let a thousand flowers bloom”, it hoped that trialling several different ways of working would give a clearer picture of patient safety, the patient experience, and how it works for both pharmacists and GPs.

The DMIRS is currently operating across four areas of England — the north east, London, Devon and the east Midlands — but the new five-year GP contract, which was agreed between NHS England and the British Medical Association in February 2019, confirmed plans to roll out the scheme nationally “as rapidly as possible”.

Keith Ridge, chief pharmaceutical officer for England, also told the conference that GP referral to DMIRS could be a “game changer” for pharmacy.

He said that if the DMIRS scheme was rolled out nationally it should be done as a “programme management system”, which would “guarantee the quality of care”.

Joshua also told the congress, held at ExCeL London on 7–8 June 2019, that online access to the NHS Urgent Medicine Supply Advanced Service (NUMSAS), which is also being run as a pilot across England, will soon be expanded to cover the whole country.

The scheme is currently being trialled in Manchester, where patients receive the same assessment via the NHS website as they would if they rang NHS 111.

Pharmacists providing the NUMSAS service interact with it in the same way as they would if the referral came via a phone call, and patients accessing the service on their mobile phones or devices are given a code that they must show when they visit the pharmacy to collect their medicine.

“At the moment, 2% of calls to NHS 111 are out-of-hours emergency medicine supply calls, so if we can shift that online that would free up a huge amount of capacity for the telephone service,” Joshua said.

Joshua also said that in some parts of the country, NUMSAS operators are switching off the ability for call handlers to refer calls for emergency medicine supply to GP out-of-hours services, meaning they have to be referred to pharmacists via NUMSAS.

The most up-to-date NHS England figures show that NUMSAS received around 15,000 referrals per month from NHS 111 in March 2019, Joshua said.

In March 2019, NHS England confirmed that the NUMSAS pilot would be extended for a further six months until 30 September 2019, after having already extended the pilot twice since its launch in December 2016.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206645

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.